Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · IEX Real-Time Price · USD
3.000
-0.130 (-4.15%)
At close: Jul 19, 2024, 4:00 PM
3.090
+0.090 (3.00%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States.
The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients.
Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Arcadia Biosciences, Inc.
| Country | United States |
| Founded | 2002 |
| IPO Date | May 15, 2015 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 21 |
| CEO | Thomas J. Schaefer |
Contact Details
Address: 202 Cousteau Place, Suite 105 Davis, X1 95618 X1 | |
| Phone | 530-756-7077 |
| Website | arcadiabio.com |
Stock Details
| Ticker Symbol | RKDA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001469443 |
| CUSIP Number | 039014204 |
| ISIN Number | US0390143032 |
| Employer ID | 81-0571538 |
| SIC Code | 0100 |
Key Executives
| Name | Position |
|---|---|
| Stanley E. Jacot Jr. | President, Chief Executive Officer and Director |
| Thomas J. Schaefer | Chief Financial Officer and Corporate Secretary |
| Tracy Baker | Senior Vice President of Seamless Technical Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 8, 2024 | 8-K | Current Report |
| Jul 1, 2024 | 8-K | Current Report |
| May 20, 2024 | 8-K | Current Report |
| May 17, 2024 | 8-K | Current Report |
| May 16, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 16, 2024 | DEF 14A | Other definitive proxy statements |
| May 13, 2024 | 10-Q | Quarterly Report |
| May 9, 2024 | 8-K | Current Report |
| Apr 29, 2024 | 10-K/A | [Amend] Annual report |
| Mar 28, 2024 | 10-K | Annual Report |